Okonkwo Ogugua Ndubuisi, Hassan Adekunle Olubola, Akanbi Toyin, Umeh Victor Chukwuebuka, Ogunbekun Oladapo Oluwadamilola
Department of Ophthalmology, Eye Foundation Retina Institute, Lagos, Nigeria.
Department of Ophthalmology, Eye Foundation Hospital, Abuja, Nigeria.
Taiwan J Ophthalmol. 2020 Oct 19;11(3):305-311. doi: 10.4103/tjo.tjo_51_20. eCollection 2021 Jul-Sep.
The purpose of this study is to describe a surgical technique and report the functional outcome of treating nonarteritic central retinal artery occlusion (CRAO) in 2 eyes of two consecutive male patients. Two males (A) and (B) presented 6 days and few hours, respectively, after symptom onset with the clinical features typical of CRAO, including sudden severe deterioration of vision to counting fingers and a cherry-red spot in the left and right fovea, respectively. While A had been on recent treatment for hypertension and hyperlipidemia, B had no significant medical history. Both patients underwent surgery, A, 9 days, and B, <15 h after symptom onset. Surgery involved a vitrectomy, lowering of intraocular pressure (<3 mmHg), and gradual increase of arterial pressure to 165/100 mmHg (through the slow injection of intravenous adrenaline). Intraoperatively, this resulted in immediate perfusion and visible dilation of the blood-filled central retinal artery (CRA) and retinal arteriolar network and dilatation of the central retinal vein. The final vision settled to 6/60 in A and 6/36+1 in B. Although preoperative macular infarction persisted in both eyes as demonstrated by optical coherence tomography angiography, both patients claim a convincing subjective visual benefit. The procedure appeared to have positively changed the natural history of the disease in both eyes. Vitrectomy with the manipulation of intraocular and arterial pressures significantly increases ocular perfusion along the entire CRA, which can dislodge CRA thrombo-emboli and has the potential to restore retinal perfusion and improve visual outcome if undertaken before irreversible retina damage. This is a relatively straightforward technique and should join the list of surgical techniques for treating CRAO.
本研究的目的是描述一种手术技术,并报告连续两名男性患者双眼治疗非动脉性视网膜中央动脉阻塞(CRAO)的功能结果。两名男性患者(A)和(B)分别在症状出现后6天和数小时就诊,具有CRAO的典型临床特征,包括视力突然严重下降至数指,左眼和右眼黄斑分别出现樱桃红斑。A近期接受过高血压和高脂血症治疗,而B无重大病史。两名患者均在症状出现后9天(A)和<15小时(B)接受了手术。手术包括玻璃体切除术、降低眼压(<3 mmHg),并通过缓慢静脉注射肾上腺素将动脉压逐渐升至165/100 mmHg。术中,这导致视网膜中央动脉(CRA)和视网膜小动脉网络立即灌注并可见扩张,以及视网膜中央静脉扩张。A的最终视力稳定在6/60,B的最终视力稳定在6/36+1。尽管光学相干断层扫描血管造影显示双眼术前黄斑梗死持续存在,但两名患者均称主观视觉受益显著。该手术似乎积极改变了双眼疾病的自然病程。通过操纵眼内压和动脉压进行玻璃体切除术可显著增加沿整个CRA的眼部灌注,这可以清除CRA血栓栓塞,并且如果在视网膜发生不可逆损伤之前进行,有可能恢复视网膜灌注并改善视觉结果。这是一种相对简单的技术,应列入治疗CRAO的手术技术清单。